Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

High-throughput small-angle X-ray scattering reveals effective structure factor transitions linked to high-concentration antibody viscosity.

mAbs·2026

Same author

Molecular Modeling and machine learning for predicting high-concentration antibody viscosity.

Advanced drug delivery reviews·2026

Same author

Predicting Subcutaneous Antibody Bioavailability Using Ensemble Protein Language Models.

Molecular pharmaceutics·2025

Same author

Physics-guided estimation of mean first-passage times from censored nucleation trajectories.

The Journal of chemical physics·2025

Same author

Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learning.

mAbs·2025

Same author

Investigating the Mechanisms of Antibody Binding to Alpha-Synuclein for the Treatment of Parkinson's Disease.

Molecular pharmaceutics·2024

Search research articles

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

Machine Learning Models for Predicting Monoclonal Antibody Biophysical Properties from Molecular Dynamics Simulations

I-En Wu¹, Lateefat Kalejaye¹, Pin-Kuang Lai¹

¹Department of Chemical Engineering and Materials Science, Stevens Institute of Technology, Hoboken 07030 New Jersey.

Molecular Pharmaceutics

|November 28, 2024

Summary

This summary is machine-generated.

This study introduces machine learning and deep learning models to predict monoclonal antibody (mAb) developability. These models accurately forecast critical biophysical properties, accelerating therapeutic antibody development and reducing costs.

Keywords:

deep learning developability machine learning molecular dynamics simulation monoclonal antibody

More Related Videos

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

Area of Science:

Biotechnology
Computational Biology
Pharmaceutical Sciences

Background:

Monoclonal antibodies (mAbs) are crucial therapeutics, but their development is lengthy and costly.
Assessing mAb developability early is vital for therapeutic success.
Key factors include biophysical properties like aggregation, solubility, and viscosity.

Purpose of the Study:

To develop and validate machine learning (ML) and deep learning (DL) models for predicting mAb biophysical properties.
To assess the predictive performance of these models against existing methods.
To introduce a novel DL model, DeepSP, for predicting spatial aggregation and charge properties.

Main Methods:

Utilized a dataset of 12 biophysical properties for 137 antibodies.
Employed full-length antibody molecular dynamics simulations.
Applied machine learning techniques and a new deep learning model (DeepSP) for property prediction.

Main Results:

Developed ML models that outperform previous methods in predicting most biophysical properties.
The DeepSP model achieved comparable predictive accuracy to molecular dynamics simulations.
DeepSP significantly reduced computational time for property prediction.

Conclusions:

The developed ML and DL models offer efficient and accurate prediction of mAb developability.
DeepSP provides a faster alternative to traditional simulations for assessing antibody properties.
Freely available code and a web application (AbDev) facilitate broader adoption and accelerate drug development.